💉 RETATRUTIDE 3D – 10 MG / PEN – 3 ML PEN – 3D PHARMA
- 💉 Product Type
- Dual/Triple Incretin-Based Metabolic Peptide / Prefilled Injectable Pen
- 💉 Active Ingredient
- Retatrutide
- Formula: C₂₂₁H₃₄₂N₄₆O₆₈
- 💉 Description
- RETATRUTIDE 3D 10 MG Pen by 3D PHARMA is a ready-to-use prefilled injectable pen containing 10 MG of Retatrutide in 3 ML. Retatrutide is an investigational multi-receptor peptide designed to support weight management, metabolic regulation, appetite control, and glucose homeostasis through simultaneous activation of multiple metabolic pathways.
- Unlike single-pathway therapies, Retatrutide has been investigated for its ability to activate GLP-1, GIP, and glucagon receptors, offering a comprehensive approach to metabolic regulation. This multi-agonist mechanism has shown promising results in clinical research involving body weight reduction and metabolic health.
- 💉 Composition & Form
Active Ingredient: Retatrutide
Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Strength: 10 MG per pen
Volume: 3 ML
Form: Ready-to-use injectable solution
Presentation: 1 prefilled pen
Administration: Subcutaneous injection
Activates GLP-1 receptors to reduce appetite and increase satiety.
Stimulates GIP receptors, supporting glucose-dependent insulin secretion.
Activates glucagon receptors, promoting increased energy expenditure and fat oxidation.
Slows gastric emptying, helping prolong fullness after meals.
Supports healthy glucose metabolism and insulin sensitivity.
Encourages fat loss while helping preserve lean body mass during weight reduction.
💉 Mechanism of Action (How It Works)
💉 Key Benefits
✅ Supports significant weight management goals
✅ Reduces appetite and promotes prolonged satiety
✅ Enhances fat oxidation and metabolic efficiency
✅ Supports healthy blood glucose regulation
✅ Helps preserve lean muscle mass during weight loss
✅ Convenient ready-to-use prefilled injection pen
💉 Side Effects
⚠ Nausea
⚠ Vomiting
⚠ Diarrhea or constipation
⚠ Abdominal discomfort
⚠ Decreased appetite
⚠ Injection-site irritation
⚠ Fatigue or headache
⚠ Temporary dizziness in some individuals
💉 Contraindications
❌ Pregnancy or breastfeeding
❌ History of Medullary Thyroid Carcinoma (MTC)
❌ Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2)
❌ Known hypersensitivity to Retatrutide or formulation components
❌ Severe gastrointestinal disorders unless medically supervised
💉 Technical Summary
| Property | Details |
|---|---|
| Scientific Name | Retatrutide |
| Molecular Formula | C₂₂₁H₃₄₂N₄₆O₆₈ |
| Classification | GLP-1 / GIP / Glucagon Receptor Agonist |
| Dosage Form | Prefilled Injectable Pen |
| Strength | 10 MG / Pen |
| Volume | 3 ML |
| Route of Administration | Subcutaneous Injection |
| Storage | Refrigerate at 2–8°C. Do not freeze. |
| Formulation | Ready-to-use |
💉 Manufacturer
3D PHARMA